New Delhi, April 4 -- Anthropic has acquired Coefficient Bio in a deal valued at around $400 million, bringing a small but specialised team into its growing healthcare and life sciences division. The move signals a sharper focus on domain-specific AI, particularly in areas like drug discovery and research workflows.

The acquisition comes shortly after a reported source code leak involving Anthropic's Claude system, putting the spotlight on how AI companies balance rapid expansion with security and reliability.

Anthropic's strategy has been evolving beyond general-purpose AI tools toward more specialised applications. With Coefficient Bio, the company adds capabilities designed for complex biotech workflows, ranging from research plannin...